BBVA USA Bancshares’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,046
Closed -$540K 535
2020
Q1
$540K Buy
3,046
+1,282
+73% +$241K 0.04% 309
2019
Q4
$337K Buy
1,764
+133
+8% +$24K 0.02% 432
2019
Q3
$274K Buy
+1,631
New +$266K 0.02% 336
2018
Q4
Sell
-1,217
Closed -$232K 543
2018
Q3
$232K Sell
1,217
-262
-18% -$48.1K 0.01% 502
2018
Q2
$247K Sell
1,479
-933
-39% -$150K 0.02% 481
2018
Q1
$406K Sell
2,412
-1,673
-41% -$281K 0.03% 401
2017
Q4
$668K Sell
4,085
-2,187
-35% -$392K 0.04% 326
2017
Q3
$1.28M Sell
6,272
-1,490
-19% -$347K 0.08% 224
2017
Q2
$1.89M Buy
7,762
+96
+1% +$22.6K 0.12% 165
2017
Q1
$1.83M Sell
7,666
-1,640
-18% -$382K 0.12% 166
2016
Q4
$1.95M Sell
9,306
-986
-10% -$204K 0.14% 151
2016
Q3
$2.37M Sell
10,292
-1,174
-10% -$287K 0.17% 128
2016
Q2
$2.65M Sell
11,466
-7,100
-38% -$1.64M 0.2% 119
2016
Q1
$4.98M Sell
18,566
-5,379
-22% -$1.54M 0.38% 66
2015
Q4
$7.48M Buy
23,945
+953
+4% +$284K 0.56% 44
2015
Q3
$6.25M Buy
22,992
+9
+0% +$2.77K 0.49% 55
2015
Q2
$6.97M Sell
22,983
-349
-1% -$104K 0.39% 82
2015
Q1
$6.94M Buy
23,332
+1,618
+7% +$461K 0.31% 110
2014
Q4
$5.59M Buy
21,714
+557
+3% +$139K 0.25% 124
2014
Q3
$5.11M Buy
21,157
+606
+3% +$136K 0.23% 130
2014
Q2
$4.58M Sell
20,551
-15
-0.1% -$3.11K 0.2% 136
2014
Q1
$4.23M Buy
20,566
+219
+1% +$43.4K 0.19% 144
2013
Q4
$3.42M Buy
20,347
+13,677
+205% +$2.14M 0.15% 160
2013
Q3
$960K Sell
6,670
-15,352
-70% -$2.05M 0.05% 256
2013
Q2
$2.78M Buy
+22,022
New +$2.49M 0.14% 169

Other funds holding AGN

BBVA USA Bancshares's AGN Position: Q2 2020 in Review

BBVA USA Bancshares sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,046 shares — an estimated $540K sold.

BBVA USA Bancshares first reported a position in AGN in Q2 2013 and held it in 25 quarters. The position peaked at $7.48M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • BBVA USA Bancshares reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • BBVA USA Bancshares sold 3,046 Allergan plc shares in Q2 2020, an estimated $540K.
  • BBVA USA Bancshares first reported a position in Allergan plc in Q2 2013 and held it in 25 quarters.
  • BBVA USA Bancshares's Allergan plc position peaked at $7.48M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on BBVA USA Bancshares's 13F filing for Q2 2020, filed 21 Jul 2020.